Recently, the Hefei Municipal Bureau of Industry and Information Technology released the “2026 Hefei High-end Industrial Products List”. Treprostinil Injection (“The Product”, 20ml:20mg & 20ml:50mg), a self-developed product by Zhaoke Pharmaceutical (Hefei) Co., Ltd. (“Zhaoke Hefei”), a wholly-owned subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, Stock Code: 00950), was successfully listed.
